Difference between revisions of "Behaviour Modifying Drugs - Overview"
Jump to navigation
Jump to search
| (9 intermediate revisions by 3 users not shown) | |||
| Line 17: | Line 17: | ||
! Class of Drug !! Drugs !! Uses !! Side Effects | ! Class of Drug !! Drugs !! Uses !! Side Effects | ||
|- | |- | ||
| − | | '''Tranquillisers''' || Acepromazine || Sedation/restraint (no specific indication in behavioural therapy) || Hypotension, CNS stimulation, contradictory responses | + | | '''Tranquillisers''' || Acepromazine || Sedation/restraint (no specific indication in behavioural therapy) || Hypotension, CNS stimulation, contradictory responses. Caution in boxers and greyhounds |
|- | |- | ||
| − | | '''Benzodiazepines '''|| Alprazolam, Clonazepam, Clorazepate, Diazepam, Lorazepam, Oxazepam || [[Feline Fear and Stress|Acute anxiety, panic, short-term management of noise phobias]] || Hepatic necrosis after oral dosing in cats (potentially fatal), | + | | '''Benzodiazepines '''|| Alprazolam, Clonazepam, Clorazepate, Diazepam, Lorazepam, Oxazepam || [[Feline Fear and Stress|Acute anxiety, panic, short-term management of noise phobias]] || Hepatic necrosis after oral dosing in cats (potentially fatal), Sedation, ataxia, increased appetite, paradoxical excitation, amnesia |
|- | |- | ||
| '''Tricyclic Antidepressants (TCAs)''' || Amitriptyline, [[Clomipramine]] || Anxiety, separation anxiety, canine and [[Feline Aggression|feline fear aggression]], [[Indoor Marking - Cat|feline urine marking]], [[Feline Grooming Disorders|feline compulsive grooming]], stereotypy, some narcoleptic disorders || Sedation, gastrointestinal (GI) effects, dry mouth, increased thirst, urinary retention | | '''Tricyclic Antidepressants (TCAs)''' || Amitriptyline, [[Clomipramine]] || Anxiety, separation anxiety, canine and [[Feline Aggression|feline fear aggression]], [[Indoor Marking - Cat|feline urine marking]], [[Feline Grooming Disorders|feline compulsive grooming]], stereotypy, some narcoleptic disorders || Sedation, gastrointestinal (GI) effects, dry mouth, increased thirst, urinary retention | ||
| Line 29: | Line 29: | ||
| '''Azapirones''' || Busiprone || Anxiety, feline urine marking, interact aggression || Uncommon, not sedating | | '''Azapirones''' || Busiprone || Anxiety, feline urine marking, interact aggression || Uncommon, not sedating | ||
|- | |- | ||
| − | | '''Triazolopyridines''' || Trazodone || Anxiety, phobia, | + | | '''Triazolopyridines''' || Trazodone || Anxiety, phobia, separations anxiety, used primarily as an augmentation for other psychoactive drug therapies|| |
|- | |- | ||
| '''Anticonvulsants''' || Carbamazepine, Gabapentin, Levetiracetam, Phenobarbital, Potassium bromide || Behavioural problems arising from focal seizures (e.g. aggression, tail chasing) || Lethargy, ataxia, polyuria, polydipsia, polyphagia | | '''Anticonvulsants''' || Carbamazepine, Gabapentin, Levetiracetam, Phenobarbital, Potassium bromide || Behavioural problems arising from focal seizures (e.g. aggression, tail chasing) || Lethargy, ataxia, polyuria, polydipsia, polyphagia | ||
| Line 39: | Line 39: | ||
| − | Synthetic hormone analogues like megestrol acetate (Ovarid), have little or no rational use in behavioural therapy for reasons of non-specificity, and adverse effects which make their use unjustifiable. Phenothiazines such as ACP have a very varied level of effect and duration of action and affect both normal and abnormal behaviours without significantly altering emotional state, which is an out of date approach to behavioural therapy<ref | + | Synthetic hormone analogues like megestrol acetate (Ovarid), have little or no rational use in behavioural therapy for reasons of non-specificity, and adverse effects which make their use unjustifiable. Phenothiazines such as ACP have a very varied level of effect and duration of action and affect both normal and abnormal behaviours without significantly altering emotional state, which is an out of date approach to behavioural therapy<ref name="Overall" />. |
Licensed drugs have established data about their efficacy, side effects, contraindications and toxicity, which makes expected outcomes more reliable<ref>Merck Veterinary Manual (10th Edition) - [http://www.merckmanuals.com/vet/behavior.html Behaviour]. 2011 The Merck Publishing Group.</ref>. Their use is supported by one or more controlled studies. | Licensed drugs have established data about their efficacy, side effects, contraindications and toxicity, which makes expected outcomes more reliable<ref>Merck Veterinary Manual (10th Edition) - [http://www.merckmanuals.com/vet/behavior.html Behaviour]. 2011 The Merck Publishing Group.</ref>. Their use is supported by one or more controlled studies. | ||
| Line 45: | Line 45: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | ||
| − | |||
[[Category:Pharmacological Approach to Problem Behaviour]] | [[Category:Pharmacological Approach to Problem Behaviour]] | ||
| + | [[Category:JBowen prereview]] | ||
Revision as of 12:14, 9 September 2014
Although many drugs are used to treat behavioural conditions in animals, there are only three psychoactive drugs specifically licensed for use in companion animals to treat behavioural problems. These are:
- Clomipramine (EU and USA license for the treatment of separation related problems in dogs).
- Selegiline (EU License for the treatment of behavioural problems with an emotional underlying origin).
- Fluoxetine (EU and USA license for the treatment of separation anxiety in dogs, when used in combination with behavioural therapy. Subsequently withdrawn from European market).
No psychoactive drugs are licensed for use in cats. A range of other drugs are used to treat behavioural conditions, including beta-adrenoceptor antagonists, benzodiazepines, azapirones, anticonvulsants and triazolopyridines. Some of these drugs are licensed for use in a companion animal species for another condition, but many are not licensed for use in any companion animal species. Examples are listed in the table below, however, most uses listed are unapproved, care should therefore be taken with their use:
| Class of Drug | Drugs | Uses | Side Effects |
|---|---|---|---|
| Tranquillisers | Acepromazine | Sedation/restraint (no specific indication in behavioural therapy) | Hypotension, CNS stimulation, contradictory responses. Caution in boxers and greyhounds |
| Benzodiazepines | Alprazolam, Clonazepam, Clorazepate, Diazepam, Lorazepam, Oxazepam | Acute anxiety, panic, short-term management of noise phobias | Hepatic necrosis after oral dosing in cats (potentially fatal), Sedation, ataxia, increased appetite, paradoxical excitation, amnesia |
| Tricyclic Antidepressants (TCAs) | Amitriptyline, Clomipramine | Anxiety, separation anxiety, canine and feline fear aggression, feline urine marking, feline compulsive grooming, stereotypy, some narcoleptic disorders | Sedation, gastrointestinal (GI) effects, dry mouth, increased thirst, urinary retention |
| Selective Serotonin Reuptake Inhibitors (SSRIs) | Fluoxetine, Fluvoxamine, Paroxetine, Sertraline | Aggression, canine separation anxiety, compulsive disorders, feline urine marking | Lethargy, inappetence, anorexia, GI effects |
| Beta Blockers | Propranolol | Situational anxiety, social anxiety, augmentation therapy for SRI/SSRIS drugs | Bradycardia, lethargy, hypotension, syncope |
| Azapirones | Busiprone | Anxiety, feline urine marking, interact aggression | Uncommon, not sedating |
| Triazolopyridines | Trazodone | Anxiety, phobia, separations anxiety, used primarily as an augmentation for other psychoactive drug therapies | |
| Anticonvulsants | Carbamazepine, Gabapentin, Levetiracetam, Phenobarbital, Potassium bromide | Behavioural problems arising from focal seizures (e.g. aggression, tail chasing) | Lethargy, ataxia, polyuria, polydipsia, polyphagia |
| Glial Modulators | Propentofylline | Reduced activity in dogs (as an adjunct therapy for dogs with cognitive dysfunction syndrome) | |
| Monoamine Oxidase Inhibitors (MAO-Is) | Selegiline | Canine and feline cognitive dysfunction syndrome, fear related problems, spraying, hyperactivity, compulsive/stereoptypical disorders, specific phobias | GI effects, restlessness or lethargy, anorexia |
Synthetic hormone analogues like megestrol acetate (Ovarid), have little or no rational use in behavioural therapy for reasons of non-specificity, and adverse effects which make their use unjustifiable. Phenothiazines such as ACP have a very varied level of effect and duration of action and affect both normal and abnormal behaviours without significantly altering emotional state, which is an out of date approach to behavioural therapy[1].
Licensed drugs have established data about their efficacy, side effects, contraindications and toxicity, which makes expected outcomes more reliable[2]. Their use is supported by one or more controlled studies.